Arie Perry
University of California, San Francisco
H-index: 120
North America-United States
Top articles of Arie Perry
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Targeted DNA Sequencing Reveals Molecular Factors Associated with Clinical Outcomes in Recurrent Glioblastoma | Neurosurgery | Nadeem Al-Adli William Chen Jacob Young Kanish Mirchia Zain Peeran | 2024/4/1 |
Adult neuromuscular choristoma, a rare peripheral nerve pathology: illustrative case | Journal of Neurosurgery: Case Lessons | Ashley Ricciardelli Alex Flores Hsiang-Chih Lu Ekin Guney Arie Perry | 2024/1/29 |
NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors | Brain Pathology | Kathryn L Eschbacher Quynh T Tran Evgeny A Moskalev Sarah Jenkins Karen Fritchie | 2024/3/24 |
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance | Nature communications | Harish N Vasudevan Emily Payne Cyrille L Delley S John Liu Kanish Mirchia | 2024/1/12 |
Molecular and clinicopathologic characteristics of CNS embryonal tumors with BRD4::LEUTX fusion | Acta neuropathologica | Zhichao Wu Sharika Rajan Hye-Jung Chung Mark Raffeld Pavalan Panneer Selvam | 2022/12 |
Epigenetic reprogramming shapes the cellular landscape of schwannoma | Nature communications | S John Liu Tim Casey-Clyde Nam Woo Cho Jason Swinderman Melike Pekmezci | 2024/1/12 |
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade | Acta Neuropathologica | Sara Hadad Rohit Gupta Nancy Ann Oberheim Bush Jennie W Taylor Javier E Villanueva-Meyer | 2024/6 |
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the … | Sabine Mueller Jason Fangusaro Arzu Onar Thomas Thomas S Jacques Pratiti Bandopadhayay | 2024/3/1 | |
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations | Free Neuropathology | Ilay Caliskan Rufei Lu Cristine Szu Lyn Ding Francineide Sadala de Souza Arie Perry | 2024/1 |
XX (XX), 1–1, 2024| https://doi. org/10.1093/neuonc/noae030| Advance Access date 23 February 2024 | Sabine Mueller Jason Fangusaro Arzu Onar Thomas Thomas S Jacques Pratiti Bandopadhayay | 2024 | |
Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients | Justin Z Wang Alexander P Landry David R Raleigh Felix Sahm Kyle M Walsh | 2024/5/2 | |
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas | Neuro-oncology | Atsuro Saijo Hirokazu Ogino Nicholas A Butowski Meghan R Tedesco David Gibson | 2024/2/1 |
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features | Neuro-oncology | Abrar Choudhury William C Chen Calixto-Hope G Lucas James C Bayley Akdes S Harmanci | 2023/3/1 |
PATH-23. CLINICOPATHOLOGIC ANALYSIS OF NOVEL METHYLATION CLUSTERS OF IDH-WILDTYPE DIFFUSE GLIOMAS | Neuro-Oncology | Omkar Singh Kenneth Aldape Zied Abdullaev Rust Turakulov Felipe Andreiuolo | 2023/11/1 |
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses | Nature medicine | William C Chen Abrar Choudhury Mark W Youngblood Mei-Yin C Polley Calixto-Hope G Lucas | 2023/12 |
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups | Philipp Karschnia Marion Smits Guido Reifenberger Emilie Le Rhun Benjamin M Ellingson | 2023/11/1 | |
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS | Blood Advances | Ekin Guney Calixto-Hope G Lucas Kunwar Singh Melike Pekmezci Sebastian Fernandez-Pol | 2023/7/11 |
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification | Acta neuropathologica | Michaela-Kristina Keck Martin Sill Andrea Wittmann Piyush Joshi Damian Stichel | 2023/1 |
PATH-02. NOVEL SOX10 INDEL MUTATIONS DRIVE SCHWANNOMAS THROUGH IMPAIRED TRANSACTIVATION OF MYELINATION GENE PROGRAMS | Neuro-Oncology | Erik Williams Ajay Ravindranathan Rohit Gupta Nicholas Stevers Abigail Suwala | 2023/11/1 |
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs | Neuro-oncology | Erik A Williams Ajay Ravindranathan Rohit Gupta Nicholas O Stevers Abigail K Suwala | 2023/12/1 |
Co-Authors
